Document is current
Any future updates will be listed below
-
Authors
Srinoulprasert, Yuttana
Sirisuthivoranunt, Surachet
Sripatumtong, Chattip
Tansit, Tunsuda
Yan, Chadakan
Apinuntham, Chalermkwan
Techapichetvanich, Thanya
Eimpunth, Sasima
Manuskiatti, Woraphong
Wanitphakdeedecha, Rungsima https://orcid.org/0000-0002-3926-2193
-
Clinical Trials BETA
Clinical trials referenced in this document:
tctr20211215001 at Thai Clinical Trials RegistryDocuments that mention this clinical trial
A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A
https://doi.org/10.1007/s13555-025-01530-y
-
Funding
Funding for this research was provided by:
Faculty of Medicine Siriraj Hospital, Mahidol University
- License Information
-
More Information
Article History
Received: 23 June 2025
Accepted: 19 August 2025
First Online: 5 September 2025
Declarations
:
: The authors; Yuttana Srinoulprasert, Surachet Sirisuthivoranunt, Chattip Sripatumtong, Tunsuda Tansit, Chadakan Yan, Chalermkwan Apinuntham, Thanya Techapichetvanich, Sasima Eimpunth, Woraphong Manuskiatti, and Rungsima Wanitphakdeedecha declare that there are no competing interests related to any aspect of this study.
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Faculty of Medicine, Siriraj Hospital, Mahidol University (Si 540/2019; approval date: August 6, 2019). The clinical trial was registered with the Thai Clinical Trials Registry (TCTR) under registration no. TCTR20211215001. Informed consent was obtained from all subjects involved in the study.
